Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB4428

Introduced
5/23/24  

Caption

Biotechnology Oversight Coordination Act of 2024

Impact

The bill intends to streamline the regulatory processes surrounding biotechnology through the creation of a unified oversight structure. This means that all responsible federal agencies would have a clear coordination mechanism to handle regulatory timelines, share information, and reduce redundancies in their reviews of biotechnology products. It is posited that such improvements will enhance predictability for developers and consumers alike while ensuring robust safety standards are met in the development of these products.

Summary

SB4428, titled the Biotechnology Oversight Coordination Act of 2024, seeks to establish a dedicated interagency committee to enhance the federal government's governance of biotechnology activities. This bill arises from a recognition that biotechnology plays a crucial role in the U.S. economy by fostering the creation of innovative products, improving environmental resilience, and maintaining competitive supply chains. The Act mandates the Committee to ensure that biotechnology practices are safe while also promoting the commercialization and responsible use of biotechnological products derived from various organisms.

Contention

Despite the favorable forecast for biotechnology development, the bill could engender debates over the actual control federal agencies may exert over state-level regulations. There is potential concern regarding the balancing act between ensuring safety and promoting innovation without stifling local efforts or standards. Furthermore, the exclusion of products regulated solely by the FDA, particularly human medical products, might stir discussions about the differing levels of oversight depending on the application of biotechnology, which some stakeholders might view as inconsistent.

Additional_notes

Overall, SB4428 represents a significant step toward consolidating federal efforts to regulate biotechnology. The expected outcomes are an agile regulatory environment and the potential for enhanced economic growth through innovatively applied biotechnology while safeguarding public health and the environment.

Companion Bills

US HB8538

Related Biotechnology Oversight Coordination Act of 2024

Similar Bills

US HB8538

Biotechnology Oversight Coordination Act of 2024

US HB8333

BIOSECURE Act

US SB3558

Prohibiting Foreign Access to American Genetic Information Act of 2024

US HB7085

BIOSECURE Act

US SB4421

Agricultural Biotechnology Coordination Act of 2024

US HB8539

Agricultural Biotechnology Coordination Act of 2024

US HB8564

Elevating Biotechnology Threats Reporting Act

CA SB1378

Food Biotechnology Task Force.